AgomAb Therapeutics NV ADR (AGMB) Stock Research

Over a week ago

Agomab initiated with bullish view at B. Riley, here's why

AGMB

Jul 23, 8:21 AM

Agomab Therapeutics NV trading resumes

AGMB

Jun 29, 4:00 PM

Agomab Therapeutics NV trading halted, volatility trading pause

AGMB

Jun 29, 3:51 PM

Agomab announces NOV-ERA study design

AGMB

Jun 23, 4:10 PM

Agomab initiated with bullish view at H.C. Wainwright, here's why

AGMB

Jun 22, 6:04 AM

Agomab receives U.S. patent for AGMB-447

AGMB

Mar 26, 7:26 AM

Agomab initiated with bullish view at Leerink, here's why

AGMB

Mar 3, 6:41 AM

Agomab initiated with bullish view at JPMorgan, here's why

AGMB

Mar 3, 5:04 AM

Agomab initiated with bullish view at Morgan Stanley, here's why

AGMB

Mar 3, 5:02 AM

Opening Day: Generate Biomedicines makes public debut

+10

Mar 2, 11:26 AM

Opening Day: SpyGlass Pharma soars in debut after strongly priced IPO

+12

Feb 9, 11:02 AM

Agomab opens at $14.70, IPO priced at $16.00

AGMB

Feb 6, 12:39 PM

Agomab indicated to open at $15.50, IPO priced at $16

AGMB

Feb 6, 10:54 AM

Agomab 12.5M share IPO priced at $16.00

AGMB

Feb 5, 7:30 PM

No more stories